Navigation Links
Dialysis Corporation of America Reports Third Quarter 2009 Results
Date:11/4/2009

iated with opening new centers were $10,000 for the 3rd quarter of 2009 compared to $339,000 for the same period last year, and $204,000 for the first nine months of 2009 compared to $577,000 for the same period last year.
  • Non-cash stock compensation expense was $70,000 for the third quarter of 2009 compared to $82,000 for the same period last year, and $217,000 for the first nine months of 2009 compared to $239,000 for the same period last year.

    • Dialysis Corporation of America will be hosting a conference call in conjunction with its earnings release for the third quarter of 2009. The conference call will be held on Thursday, November 5, 2009 at 10:00 a.m. EST. The call is accessible either by dialing 1-866-814-8476 (enter attendee code: 1405582), or through simulcast on the internet at http://www.startconference.com, using conference ID 2135668. Participants may be asked to provide the title of the conference call, which is "Dialysis Corporation of America Third Quarter Earnings." A replay of the conference call will be available on the company's website, www.dialysiscorporation.com, for a period of thirty days following the conference call.

    Dialysis Corporation of America owns and operates freestanding kidney hemodialysis centers located in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, and Virginia, and provides in-hospital dialysis services on a contract basis to certain hospitals located in the those states. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis services.

    This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors inc
    '/>"/>

    SOURCE Dialysis Corporation of America
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. For People on Dialysis, Too Thin Can Be Risky
    2. For dialysis patients, skinny is dangerous
    3. Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints
    4. Traveling While on Dialysis Could Be Risky
    5. Intensive Dialysis Doesnt Save Lives of the Sickest
    6. Dialysis Drawbacks Outweigh Benefits for Some Older Patients
    7. NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour
    8. Kidney Injury While Hospitalized May Lead to Future Dialysis
    9. Texas Kidney Community Expresses Hope DC Health Care Reform Debate Can Help Drive Continued Progress in Texas Opening Needed Dialysis Facilities
    10. RainEarth (RNER) Complies with Chinese Medical Service Reforms to Provide Better and Cheaper Blood Dialysis
    11. DaVita Offers Dialysis While Patients Sleep

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/30/2009)...nt to 113 chest X-rays, study finds , , ... of patients who have abdominal/pelvic CT scans re...pose them to extra radiation, U.S. researchers say...eries were performed on 500 patients aged 9 months...ears of age. The researchers concluded that 35.3 p...
    (Date:11/30/2009)...unique online and mobile tool empowers patients to...isions ,, ARLINGTON, Va., Nov. 30 /PRNewswir...#1 HIV/AIDS resource online, today launched My Hea...V/AIDS-infected patients the ability to save, trac...d with sponsorship from Merck, is available at ww...
    (Date:11/30/2009)...Nov. 30 Tyco Internation...10 annual general meeting of shareholders will be ...tral European time at the Park Hyatt Zurich Hotel,...egistered shareholders as of January 11, 2010 (the...al general meeting. Additionally, individuals who...
    (Date:11/30/2009)... and extensive discussion in the scientific commun...ealth Care (IQWiG) presents its methods for evalua...stitute can now apply these methods when working o... Committee (G-BA). The method developed by IQWiG i...KV-Spitzenverband [National Association of Health ...
    (Date:11/30/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Key Players and Innovative Start-Ups i...ts, pharma, food and drinks ,, http://www.rep...Start-Ups-in-Nutraceuticals-Emerging-strategies-in...traceuticals are bioactive compounds with properti...
    Breaking Medicine News(10 mins):Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
    ...ver for those who prefer relaxing with a good cup ...ed by researchers from Charite Hospital Universita...European Heart Journal, has come out with a study ...hich protect the heart and have anti-cancer effect...
    ... in adolescents and young adults was associated wi...heart//, researchers report in Circulation: Journa...udy of American Indians, average age 26.5, those w... ventricular wall thickness, higher left ventricul...
    ...er week are at greater risk of developing osteoart...ccording to research conducted by the University o...is characterised by joint pain, which can be relie...s arose in the long-distance joggers' knees, said ...
    ...age healing through mantras! Sanskrit scholars of ...rsity// have initiated a research project, said to...es through Vedic chants. A state-of-the-art a...icipating in the research. The lab would inv...
    ... is a boon for the kith and kin of those people wh...vaccine is currently available in 33 countries all...rp & Dohme. This vaccine was formed by Professor I...g contender for Nobel Prize. In the middle E...
    ...California heaved a sigh of relief when the health...tween the meningitis// and the encephalitis cases ... have clearly indicated that the bacteria, which c...erial infection. An elementary school studen...
    Other Medicine News:Health News:Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement 2Health News:Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement 3
    (Date:11/30/2009)...L, Wash., Nov. 30 SCOLR ...at on November 25, 2009, the NYSE Amex LLC (the "E...d the Company,s plan to comply with its previously...)(iv) of the Exchange Company Guide. Specifically...stained losses which were so substantial in relati...
    (Date:11/30/2009)...STON, S.C., Nov. 30 The Eleventh A...", will be held at the Charleston Place Hotel in t...r 3-4, 2009. Dr. Cheryl Liljestrand, Dr. Harry Gu...s with Stipkala LLC, will attend. SEBIO 2009 prom...nvestors, scientists, entrepreneurs, and service p...
    (Date:11/30/2009)...W YORK, Nov. 30 Reportlinker.com a...lable in its catalogue: ,, Cardiac Defibrillat..., http://www.reportlinker.com/p0164315/Cardiac-De...ort.html ,, Cardiovascular disease (CVD) is o...den cardiac arrest survivors are prone to arrhythm...
    Breaking Medicine Technology:SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 1International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 2International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 3International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 4International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 5International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 6International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 7Sage Software Healthcare Inc Celebrates National Health Center Week 54311 1Sage Software Healthcare Inc Celebrates National Health Center Week 54311 2Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 1Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 2
    ...S WIRE)--Apr 14, 2007 - In a late-breaker,presenta...sociation,for the Study of the Liver (EASL), resea... analysis of the PROVE 1 clinical trial,which is ... with,the investigational hepatitis C protease inh...h pegylated interferon (peg-IFN) and,ribavirin (RB...
    ...RNewswire-FirstCall/ -- ACCESS,PHARMACEUTICALS, IN...mechanism of ProLindac,s anticancer activity will ... Cancer Research (AACR) 2007,annual meeting in Los... two poster presentations describe preclinical stu...inent institutes in France. , "We are delighted to...
    Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 2Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 3Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 4
    Silicone Wedge (137 Style)
    Silicone Tire (281 Style)
    Silicone Strip (225 Style)
    Silicone Boat (60 Style)
    Medicine Products: